Sanofi drops plans for mRNA Covid-19 vaccine amid BioNTech-Pfizer, Moderna success Ruchika Sharma30 Sept 2021 1:26 PM ISTParis: Sanofi is dropping plans for its own mRNA-based Covid-19 vaccine because of the dominant role of the BioNTech-Pfizer alliance as well as...
Covid-19 vaccine boosters could mean billions for drugmakers: Report Ruchika Sharma27 Sept 2021 9:30 AM ISTNew Delhi: Billions more in profits are at stake for some vaccine makers as the US moves toward dispensing Covid-19 booster shots to shore up...
FIRST: Pfizer, BioNTech get USFDA emergency use nod for COVID vaccine booster Ruchika Sharma23 Sept 2021 11:30 AM ISTNew York: Pfizer Inc. and BioNTech SE have recently announced that the U.S. Food and Drug Administration (USFDA) has authorized for emergency use...
Data shows Covid-19 vaccine safe, protective in kids: Pfizer/BioNTech Ruchika Sharma21 Sept 2021 1:32 PM ISTNew Delhi: Pfizer Inc and BioNTech SE said on Monday their Covid-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to...
Pfizer initially rejected BioNTech offer to develop COVID vaccine MD Bureau14 Sept 2021 9:00 AM ISTLondon: US drug maker Pfizer wrongly assumed that the coronavirus outbreak would be quickly contained and thus declined the offer made by BioNTech to...
BioNTech eyes building malaria, TB vaccine production sites in Rwanda, Senegal Ruchika Sharma29 Aug 2021 9:15 AM ISTNew Delhi: COVID-19 vaccine maker BioNTech said on Friday it was looking into building malaria and tuberculosis vaccine production sites in Rwanda and...
Pfizer COVID vaccine Comirnaty gets full USFDA approval Ruchika Sharma24 Aug 2021 3:53 PM ISTNew York: Pfizer and BioNTech have recently announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application...
Pfizer-BioNTech submit data to USFDA to support COVID vaccine booster dose Ruchika Sharma18 Aug 2021 2:01 PM ISTNew York: Pfizer Inc. and BioNTech SE have recently announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration...
India in discussion to buy 50 million Pfizer COVID vaccine doses: Report Ruchika Sharma13 Aug 2021 11:00 AM ISTNew Delhi: India is in talks to buy 50 million doses of Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine, the Wall Street...
Third dose of COVID-19 vaccine strongly shields against Delta variant, says Pfizer data Dr. Shravani Dali31 July 2021 7:00 AM ISTA third dose of the Pfizer/BioNTech COVID-19 vaccine can enhance protection against the Delta variant as compared to the standard two doses,...
BioNTech to buy Kite Gaithersburg manufacturing facility, Neoantigen TCR cell therapy RnD platform Ruchika Sharma20 July 2021 9:00 AM ISTGermany: BioNTech SE and Kite, a Gilead Company have recently announced that the two companies have entered into a purchase agreement...
Pfizer-BioNTech COVID vaccine to be reviewed by USFDA by January Ruchika Sharma18 July 2021 10:00 AM ISTNew Delhi: The U.S. health regulator will review Pfizer and German partner BioNTech SE's application for full approval of their COVID-19...
